Compare VNET Group Inc (VNET) vs Viatris Inc (VTRS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
VNET Group Inc vs Viatris Inc — how do they compare? VNET Group Inc trades at $5.53 (market cap $1.47B), while Viatris Inc trades at $17.64 (market cap $20.03B). The key difference: Viatris Inc is far larger — about 13.6× VNET Group Inc's market cap, and Viatris Inc pays a 2.75% dividend while VNET Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold VNET Group Inc for 16 Days and Viatris Inc for 57 Days on average.
| VNET | VTRS | |
|---|---|---|
Market Cap | $1.47B | $20.03B |
Volume | 4,955,295 | 14,109,977 |
Sector | Technology | Health |
52-Week High | $14.03 | $18.27 |
52-Week Low | $5.13 | $9.74 |
Typical Hold Time | 16 Days | 57 Days |
Enterprise Value | $5.04B | $32.15B |
Dividend Yield | — | 2.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
VNET trades at $5.53, up 2.6% today but near 52-week lows. The technical picture is bearish with negative moving averages, while fundamentals show revenue growth to $9.95B in 2025 but persistent losses with a -22.18% net margin. Recent strategic investments and AI infrastructure partnerships provide growth catalysts, but balance sheet concerns and negative cash flow remain challenges.
Outlook remains cautious despite 62.5% analyst buy ratings. The stock offers speculative upside from AI data center demand and recent strategic investments, but risks include heavy debt load, negative profitability, and Chinese regulatory exposure. Investors should weigh growth potential against fundamental weaknesses.
Viatris (VTRS) trades at $17.64, up 0.86% on the day, with a bullish technical signal from moving averages and oversold RSI levels. The company has beaten earnings estimates for three consecutive quarters, with Q2 2026 EPS of $0.69 exceeding expectations. Revenue for 2025 was $14.3 billion, though net income was negative. Analyst consensus is a 'Buy' with a $22.17 price target, representing 26% upside. Recent news highlights include a new drug approval in Japan and recognition as a top employer.
The outlook for VTRS is cautiously optimistic, supported by earnings beats and a positive analyst stance, but tempered by negative profit margins and high debt. Key opportunities include operational cash flow strength and pipeline progress, while risks involve sustained profitability challenges and competitive pressures in the generics market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About VNET Group Inc
VNET Group, formerly 21Vianet, is a leading carrier-neutral data center services provider in China. It operates a dual-core strategy: a large-scale retail business serving over 7,000 enterprise customers and an aggressive wholesale segment (Hyperscale 2.0) designed to meet the high-density power and cooling demands of large-scale AI and cloud platforms.
Read more on VNET →About Viatris Inc
Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →
